Gene Symbol | EGR1 |
Entrez ID | 1958 |
Uniprot ID | P18146 |
Description | early growth response 1 |
Chromosomal Location | chr5: 138,465,490-138,469,315 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter |
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IEA |
BP |
GO:0001666 |
response to hypoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
ISS |
BP |
GO:0002931 |
response to ischemia |
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply. |
ISS |
BP |
GO:0006366 |
transcription from RNA polymerase II promoter |
The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). |
IDA |
BP |
GO:0009749 |
response to glucose |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus. |
IEA |
BP |
GO:0030217 |
T cell differentiation |
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex. |
IEA |
BP |
GO:0030509 |
BMP signaling pathway |
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IEA |
BP |
GO:0032868 |
response to insulin |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
IEA |
BP |
GO:0033233 |
regulation of protein sumoylation |
Any process that modulates the frequency, rate or extent of the addition of SUMO groups to a protein. |
IDA |
BP |
GO:0035914 |
skeletal muscle cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle. |
IEA |
BP |
GO:0042981 |
regulation of apoptotic process |
Any process that modulates the occurrence or rate of cell death by apoptotic process. |
IEA |
BP |
GO:0044849 |
estrous cycle |
A type of ovulation cycle, which occurs in most mammalian therian females, where the endometrium is resorbed if pregnancy does not occur. |
ISS |
BP |
GO:0045080 |
positive regulation of chemokine biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines. |
ISS |
BP |
GO:0045893 |
positive regulation of transcription, DNA-templated |
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
IDA |
BP |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IDA|IGI|IMP |
BP |
GO:0046886 |
positive regulation of hormone biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones. |
ISS |
BP |
GO:0050725 |
positive regulation of interleukin-1 beta biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 beta. |
ISS |
BP |
GO:0060337 |
type I interferon signaling pathway |
A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
TAS |
BP |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia |
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus. |
IEA |
BP |
GO:0070498 |
interleukin-1-mediated signaling pathway |
A series of molecular signals initiated by the binding of interleukin-1 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IMP |
BP |
GO:0071480 |
cellular response to gamma radiation |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum. |
IEA |
BP |
GO:0071504 |
cellular response to heparin |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heparin stimulus. |
ISS |
BP |
GO:0071506 |
cellular response to mycophenolic acid |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mycophenolic acid stimulus. |
ISS |
BP |
GO:0072110 |
glomerular mesangial cell proliferation |
The multiplication or reproduction of glomerular mesangial cells, resulting in the expansion of the population. |
ISS |
BP |
GO:0072303 |
positive regulation of glomerular metanephric mesangial cell proliferation |
Any process that increases the frequency, rate or extent of metanephric glomerular mesangial cell proliferation. |
ISS |
BP |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway |
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
IEA |
BP |
GO:0098759 |
cellular response to interleukin-8 |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-8 stimulus. |
IDA |
BP |
GO:2000182 |
regulation of progesterone biosynthetic process |
Any process that modulates the frequency, rate or extent of progesterone biosynthetic process. |
ISS |
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IDA|ISS |
CC |
GO:0005654 |
nucleoplasm |
That part of the nuclear content other than the chromosomes or the nucleolus. |
IDA|TAS |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA|ISS |
MF |
GO:0000976 |
transcription regulatory region sequence-specific DNA binding |
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon. |
IDA |
MF |
GO:0000977 |
RNA polymerase II regulatory region sequence-specific DNA binding |
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II. |
IDA |
MF |
GO:0001077 |
transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter. |
IEA |
MF |
GO:0003677 |
DNA binding |
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
IDA |
MF |
GO:0003700 |
transcription factor activity, sequence-specific DNA binding |
Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
IDA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0008270 |
zinc ion binding |
Interacting selectively and non-covalently with zinc (Zn) ions. |
IDA |
MF |
GO:0010385 |
double-stranded methylated DNA binding |
Interacting selectively and non-covalently with double-stranded methylated DNA. Methylation of cytosine or adenine in DNA is an important mechanism for establishing stable heritable epigenetic marks. |
IDA |
MF |
GO:0035035 |
histone acetyltransferase binding |
Interacting selectively and non-covalently with the enzyme histone acetyltransferase. |
IPI |
MF |
GO:0043565 |
sequence-specific DNA binding |
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
IDA |
MF |
GO:0044729 |
hemi-methylated DNA-binding |
Interacting selectively and non-covalently with double-stranded hemi-methylated DNA at replication foci (one strand methylated, while the other strand is unmethylated). Methylation of cytosine or adenine in DNA is an important mechanism for establishing stable heritable epigenetic marks. |
IDA |
MF |
GO:1990841 |
promoter-specific chromatin binding |
Interacting selectively and non-covalently with a section of chromatin that is associated with gene promoter sequences of DNA. |
IDA |
Domain ID | Description |
---|---|
IPR013083 |
Zinc finger, RING/FYVE/PHD-type |
IPR013087 |
Zinc finger C2H2-type |
IPR021839 |
Protein of unknown function DUF3432 |
IPR021849 |
Protein of unknown function DUF3446 |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04371 |
Apelin signaling pathway |
KEGG |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
KEGG |
hsa05020 |
Prion diseases |
KEGG |
hsa05166 |
HTLV-I infection |
KEGG |
WP2431 |
Spinal Cord Injury |
WikiPathways |
WP734 |
Serotonin Receptor 4/6/7 and NR3C Signaling |
WikiPathways |
WP706 |
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways |
WikiPathways |
WP2884 |
NRF2 pathway |
WikiPathways |
WP34 |
Ovarian Infertility Genes |
WikiPathways |
WP481 |
Insulin Signaling |
WikiPathways |
WP2374 |
Oncostatin M Signaling Pathway |
WikiPathways |
WP3527 |
Preimplantation Embryo |
WikiPathways |
WP3594 |
Circadian rythm related genes |
WikiPathways |
WP2032 |
Human Thyroid Stimulating Hormone (TSH) signaling pathway |
WikiPathways |
WP2380 |
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway |
WikiPathways |
WP3888 |
VEGFA-VEGFR2 Signaling Pathway |
WikiPathways |
h_cdk5Pathway |
Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0003130 |
Anoxia |
C0007786 |
Brain Ischemia |
C0008370 |
Cholestasis |
C0008372 |
Intrahepatic Cholestasis |
C0020295 |
Hydronephrosis |
C0021368 |
Inflammation |
C0022116 |
Ischemia |
C0025500 |
Mesothelioma |
C0033578 |
Prostatic Neoplasms |
C0035126 |
Reperfusion Injury |
C0236736 |
Cocaine-Related Disorders |
C3495559 |
Juvenile Arthritis |
Tissue | Cell Type |
---|---|
adrenal gland |
glandular cells |
ovary |
ovarian stroma cells |
smooth muscle |
smooth muscle cells |
thyroid gland |
glandular cells |
tonsil |
non-germinal center cells |
urinary bladder |
urothelial cells |
vagina |
squamous epithelial cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15308691 |
Jansen et al. |
2004 |
Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients |
17062763 |
Corton et al. |
2007 |
Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome |
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
MDM2 |
4193 |
Q00987 |
0.63 |
PTEN |
5728 |
P60484 |
0.63 |
SRA1 |
10011 |
Q9HD15 |
0.63 |
CDKN2A |
1029 |
Q8N726 |
0.68 |
CDKN2A |
1029 |
P42771 |
0.70 |
FOSL2 |
2355 |
P15408 |
0.72 |
JUNB |
3726 |
P17275 |
0.72 |
JUND |
3727 |
P17535 |
0.72 |
MAGEB2 |
4113 |
O15479 |
0.72 |
PSMD2 |
5708 |
Q13200 |
0.72 |
MED6 |
10001 |
O75586 |
0.72 |
POP1 |
10940 |
Q99575 |
0.72 |
DNAJC8 |
22826 |
O75937 |
0.72 |
PHIP |
55023 |
Q8WWQ0 |
0.72 |
ARID2 |
196528 |
Q68CP9 |
0.72 |
SP1 |
6667 |
P08047 |
0.84 |
NFATC2 |
4773 |
Q13469 |
0.52 |
CSNK2A1 |
1457 |
P68400 |
0.55 |
JUN |
3725 |
P05412 |
0.55 |
WT1 |
7490 |
P19544 |
0.56 |
CTNNB1 |
1499 |
P35222 |
0.63 |
IL1B |
3553 |
P01584 |
0.63 |
PFDN5 |
5204 |
Q99471 |
0.63 |
SREBF2 |
6721 |
Q12772 |
0.63 |
TCF4 |
6925 |
P15884 |
0.63 |
VDR |
7421 |
P11473 |
0.63 |
LEF1 |
51176 |
Q9UJU2 |
0.63 |
TBX2 |
6909 |
Q13207 |
0.65 |
NAB2 |
4665 |
Q15742 |
0.67 |
ERBB3 |
2065 |
P21860 |
0.72 |
SNAI1 |
6615 |
O95863 |
0.73 |
NFATC1 |
4772 |
O95644 |
0.75 |
PITX1 |
5307 |
P78337 |
0.75 |
RELA |
5970 |
Q04206 |
0.75 |
NAB1 |
4664 |
Q13506 |
0.78 |
CREBBP |
1387 |
Q92793 |
0.79 |
SUMO1 |
7341 |
P63165 |
0.82 |
PSMA3 |
5684 |
P25788 |
0.87 |
CEBPB |
1051 |
P17676 |
0.88 |
EP300 |
2033 |
Q09472 |
0.90 |
TP53 |
7157 |
P04637 |
0.90 |